Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon Apr 12, 2023 10:09am
70 Views
Post# 35390458

RE:RE:Dump. Dump. Dump

RE:RE:Dump. Dump. DumpIt may be only $6K as you say but it has taken the value of 75,000,000 shares down 24%.  Not to say that it could quickly come back .
I was merely pointing out which brokerage house where the trades originated. I wasn't saying they owned the stock if that is what you are inferring.

I actually did expect something was going to happen.  i was expecting a follow up from Andrew regarding finding a new manufacturer for the Dermal Injector that he mentioned at the AGM.

As far as Shiseido with 47 days remaining before the Hearing it looks like they are not going to negotiate a deal.  They are going to take their chances at the Hearing.  I take that as bad news. I would rather see the 2 companies negotiate a deal where they jointly develop RCH-01.
<< Previous
Bullboard Posts
Next >>